Pittenger & Anderson Inc Crispr Therapeutics Ag Transaction History

Pittenger & Anderson Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$70.09 - $111.29 $2,523 - $4,006	-36 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $1,212 - $1,723	11 Added 44.0%	36 $4,000
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $806 - $1,295	8 Added 47.06%	25 $4,000
Q4 2020 Feb 11, 2021	BUY	$79.67 - $173.23 $478 - $1,039	6 Added 54.55%	17 $3,000
Q3 2020 Nov 10, 2020	BUY	$78.5 - $100.64 $863 - $1,107	11 New	11 $1,000

493

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.97B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

Stay updated on Pittenger & Anderson Inc with notifications on news.